How Pharmaceutical Innovation Benefits From Spatial Aggregation: A Perspective Based on R&D Cooperation Networks

IF 2.9 3区经济学 Q1 DEVELOPMENT STUDIES

Growth and Change Pub Date : 2025-06-19 DOI:10.1111/grow.70038

Fusen Zhao, Jianting Fan

{"title":"How Pharmaceutical Innovation Benefits From Spatial Aggregation: A Perspective Based on R&D Cooperation Networks","authors":"Fusen Zhao, Jianting Fan","doi":"10.1111/grow.70038","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>This paper empirically analyzes the relationship between pharmaceutical industry agglomeration and enterprise innovation based on drug registration application data and pharmaceutical enterprise data in China, and explores the mechanism of the role of agglomeration in influencing innovation from a perspective of research and development (R&D) cooperation networks. It was found that the spatial agglomeration of pharmaceutical firms significantly enhanced innovation and that agglomeration contributed to innovation through three transmission pathways of R&D cooperation networks, which were whether firms were in the network, their location in the network, and the diversity of their partners in the network. The further discussion shows that there is significant regional heterogeneity in the transmission mechanism of pharmaceutical industry agglomeration through R&D cooperation networks and thus affects innovation. The results of the study provide useful insights into how to take advantage of agglomeration and further understand the relationship between agglomeration and innovation.</p>\n </div>","PeriodicalId":47545,"journal":{"name":"Growth and Change","volume":"56 3","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Growth and Change","FirstCategoryId":"96","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/grow.70038","RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DEVELOPMENT STUDIES","Score":null,"Total":0}

引用次数: 0

Abstract

This paper empirically analyzes the relationship between pharmaceutical industry agglomeration and enterprise innovation based on drug registration application data and pharmaceutical enterprise data in China, and explores the mechanism of the role of agglomeration in influencing innovation from a perspective of research and development (R&D) cooperation networks. It was found that the spatial agglomeration of pharmaceutical firms significantly enhanced innovation and that agglomeration contributed to innovation through three transmission pathways of R&D cooperation networks, which were whether firms were in the network, their location in the network, and the diversity of their partners in the network. The further discussion shows that there is significant regional heterogeneity in the transmission mechanism of pharmaceutical industry agglomeration through R&D cooperation networks and thus affects innovation. The results of the study provide useful insights into how to take advantage of agglomeration and further understand the relationship between agglomeration and innovation.

查看原文本刊更多论文

医药创新的空间集聚效应：基于研发合作网络的视角

本文基于中国药品注册申请数据和医药企业数据，实证分析了医药产业集聚与企业创新的关系，并从研发合作网络的角度探讨了集聚对创新的影响机制。研究发现，制药企业的空间集聚显著促进了创新，并通过企业是否在网络中、企业在网络中的位置以及企业在网络中合作伙伴的多样性这三条研发合作网络的传导路径促进了创新。进一步研究发现，医药产业通过研发合作网络集聚并影响创新的传导机制存在显著的区域异质性。研究结果为如何利用集聚效应提供了有益的启示，并有助于进一步理解集聚与创新的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Growth and Change Multiple-

CiteScore

6.40

自引率

3.10%

发文量

期刊介绍： Growth and Change is a broadly based forum for scholarly research on all aspects of urban and regional development and policy-making. Interdisciplinary in scope, the journal publishes both empirical and theoretical contributions from economics, geography, public finance, urban and regional planning, agricultural economics, public policy, and related fields. These include full-length research articles, Perspectives (contemporary assessments and views on significant issues in urban and regional development) as well as critical book reviews.